What is the main corporate governance change announced in this 8-K?

The primary change is the amendment to the Articles of Incorporation, approved by shareholders, which now allows shareholders who collectively own 20% or more of the company's common stock to call special meetings. The Board of Directors also amended the Bylaws to establish the procedures for such meetings.

Were there any significant shareholder proposals that were not approved?

Yes, a shareholder proposal that aimed to lower the threshold for shareholders to call a special meeting to 10% of common stock ownership was not approved by shareholders. This indicates a preference for a higher threshold, aligning with the company-sponsored amendment requiring 20% ownership.

How did shareholders vote on the company's executive compensation?

Shareholders provided advisory approval for the company's executive compensation, with a significant majority voting in favor.

What is the significance of the 20% ownership threshold for calling special meetings?

This change gives a substantial minority of shareholders more power to directly influence the company's agenda by being able to call a special meeting outside of the annual meeting cycle. This could lead to increased shareholder activism or proposals being brought forth more readily by large institutional investors.

ELV 8-K: Shareholder Matters & Corporate Changes

Summary

Elevance Health, Inc. (then Anthem, Inc.) filed an 8-K on May 16, 2018, detailing key corporate governance changes and shareholder voting outcomes from its Annual Meeting held on the same day. The most significant development for investors was the shareholder approval of amendments to the Articles of Incorporation. These amendments now permit shareholders owning 20% or more of the company's common stock to call special meetings, a change from previous provisions. This shift grants a substantial block of shareholders greater ability to convene meetings outside of the regular annual cycle, potentially influencing corporate strategy or actions. The filing also reflects strong shareholder support for the re-election of directors, the ratification of Ernst & Young LLP as the independent auditor for 2018, and advisory approval of executive compensation. Notably, a shareholder proposal to lower the threshold for calling special meetings to 10% was rejected, indicating that the approved 20% threshold represents a compromise that satisfied the majority of shareholders. Investors should monitor how this enhanced shareholder power to call special meetings might be utilized in the future.

Key Highlights

1Shareholder approval of amendments to the Articles of Incorporation, allowing shareholders owning 20% or more of common stock to call special meetings.
2The company's Board of Directors subsequently amended the Bylaws to outline procedures for these shareholder-requested special meetings.
3Re-election of all listed director nominees (Lewis Hay III, Julie A. Hill, Antonio F. Neri, Ramiro G. Peru) to three-year terms.
4Ratification of Ernst & Young LLP as the company's independent registered public accounting firm for 2018.
5Shareholders provided advisory approval for the company's executive compensation.
6A shareholder proposal to lower the threshold for calling special meetings to 10% was not approved.
7Filing includes the Amended and Restated Articles of Incorporation and Amended Bylaws as exhibits.

Elevance Health, Inc. 8-K Report, Bylaw Amendment (May 16, 2018)

Summary

Key Highlights

Frequently Asked Questions